Delivery Order SPE2DB24D2205-SPE2DB25FDYMB

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $39K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,795.90 firm fixed-price delivery order is for the supply of CARVEDILOL ER 80 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,420.79 for the supply of CARVEDILOL ER 20 MG CAPSULE 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 19, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,960.67 firm fixed-price delivery order is for the supply of CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,872.12 firm fixed-price delivery order is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. This contract is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,308.35 firm fixed-price delivery order is for the provision of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,556.28 firm fixed-price contract is for the supply of CARVEDILOL ER 20 MG CAPSULE 30S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,993.62 delivery order contract is for the supply of CARVEDILOL ER 10 MG CAPSULE 30S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,790.56 firm fixed-price delivery order is for the supply of CARVEDILOL ER 80 MG CAPSULE 30S, a cardiovascular medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $71,224.76, is a delivery order for the supply of 4566747201 - CARVEDILOL ER 40 MG CAPSULE 30S. The contract has a firm fixed price pricing type and a completion date of December 18, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,658.72 firm fixed-price delivery order is for 4564465582 ! CARVEDILOL ER 40 MG CAPSULE 30S, a cardiovascular medication. The contract has an ultimate completion date of May 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDYMB
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CARVEDILOL ER 80 MG CAPSULE 30S, a cardiovascular medication. The award, valued at $38,774.55, has a firm fixed price and an ultimate completion date of February 19, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:28 PM